MIR vs. AVTR, RVTY, BIO.B, NVMI, VNT, ST, TRNS, CTKB, LAB, and EYPT
Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Sensata Technologies (ST), Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), and EyePoint Pharmaceuticals (EYPT). These companies are all part of the "measuring and control equipment" industry.
Mirion Technologies vs.
Avantor (NYSE:AVTR) and Mirion Technologies (NYSE:MIR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk.
Avantor has higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.
Avantor has a net margin of 4.54% compared to Mirion Technologies' net margin of -7.84%. Avantor's return on equity of 12.24% beat Mirion Technologies' return on equity.
Avantor has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.
Avantor received 167 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 84.21% of users gave Mirion Technologies an outperform vote while only 65.36% of users gave Avantor an outperform vote.
In the previous week, Mirion Technologies had 8 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Mirion Technologies and 4 mentions for Avantor. Avantor's average media sentiment score of 1.04 beat Mirion Technologies' score of 0.83 indicating that Avantor is being referred to more favorably in the media.
Avantor currently has a consensus price target of $27.69, indicating a potential upside of 30.38%. Mirion Technologies has a consensus price target of $19.25, indicating a potential upside of 8.45%. Given Avantor's higher possible upside, equities analysts plainly believe Avantor is more favorable than Mirion Technologies.
95.1% of Avantor shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 1.3% of Avantor shares are owned by insiders. Comparatively, 2.2% of Mirion Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Avantor beats Mirion Technologies on 13 of the 19 factors compared between the two stocks.
Get Mirion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Mirion Technologies Competitors List
Related Companies and Tools
This page (NYSE:MIR) was last updated on 12/24/2024 by MarketBeat.com Staff